z-logo
open-access-imgOpen Access
The Effect of Rofecoxib/Doxazosin Treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men
Author(s) -
Mutlu Ateş,
Mustafa Karalar,
Bünyamin Yıldırım,
Fatih Pektaş,
Cemil Ay,
Mehmet Baykara,
Ti̇bet Erdoğru
Publication year - 2012
Publication title -
the annals of clinical and analytical medicine
Language(s) - English
Resource type - Journals
ISSN - 2667-663X
DOI - 10.4328/jcam.680
Subject(s) - medicine , doxazosin , rofecoxib , prostatitis , pelvic pain , chronic prostatitis/chronic pelvic pain syndrome , suppository , urology , surgery , prostate , pharmacology , biochemistry , chemistry , cancer , blood pressure , cyclooxygenase , enzyme
1 Mutlu Ates1, Mustafa Karalar1, Bünyamin Yıldırım1, Fatih Pektaş1, Cemil Ay1, Mehmet Baykara2, Tibet Erdoğru2 1Afyon Kocatepe Üniversitesi Tıp Fakültesi Üroloji A.D., Afyonkarahisar, 2Akdeniz Üniversitesi Tıp Fakültesi Üroloji A.D., Antalya, Türkiye Kronik Prostatit’de COX-II İnhibitörleri ve Alfa Blokerler / COX-II Inhibitors and Alpha Blockers at Chronic Prostatitis The Effect of Rofecoxib/Doxazosin Treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Men

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom